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Abstract
Chronic obstructive pulmonary disease (COPD), third leading cause of mortality worldwide,1 is primarily
caused by cigarette smoking in Australia.2 COPD often occurs in the presence of multi-morbidity, which is
the simultaneous occurrence of two or more chronic conditions; this is a growing concern in a health system
focused on single-disease management.3 Around 80% of older Australians have multi-morbidity, average
prevalence of chronic respiratory disease being 9.5%.4 A systematic review of COPD education programs
suggests that equipping patients with self-management skills is as important as disease knowledge.5 Studies
exploring positive effects of chronic disease-management interventions6 also underline the lack of studies
aimed at empowering patients. Although a recent Cochrane Review7 of COPD self-management
interventions shows increased health-related quality of life and decreased probability of respiratory-related
hospitalisation, similar interventions have not been consistently effective when applied in recent trials.8-10
Though interventions aimed at modifying COPD-related health behaviour have great potential, extant
literature points to need for self-management programs in primary care. There is a dearth of interventions
involving patients with multimorbidity, clinicians and other stakeholders, that can be generalisable to other
populations.11 Patients with multimorbidity are often excluded from chronic disease-management trials; a
Cochrane review12 of multi-morbidity interventions found only ten such studies. Our recent qualitative
study,13 which explored the impact of COPD diagnosis in primary care patients with co-morbidities (co-
existing chronic conditions), found suboptimal disease understanding and health-care utilisation. The above
evidence demonstrates a need for development and testing interventions to increase self-management
capacity in COPD patients with co-morbidities. Even a brief education session is effective in improving
disease knowledge and response to symptoms;14 as demonstrated by selfmanagement interventions10, 15 on
COPD which increased patient self-efficacy. Such programs do not only improve health status and prevent
hospital remissions,16 but also lead to better patientprovider relationships, self-efficacy and sense of
identity.17 With no prior study having seemed to focus on improving self-efficacy of COPD patients with co-
morbidities in primary care, our study aims to empower these patients by trialling a tailored, practice nurse -
delivered self-management program. AIMS This pre and post-test pilot study aims to trial the impact and
feasibility of a tailored self-management program for primary care COPD patients with multi-morbidity. Our
hypothesis is that at six months' follow-up, participants would have: 1. Better activation in terms of their
COPD-related health behaviour. 2. Improved knowledge and self-management capacity of COPD. 3.
Increased self-efficacy in terms of their overall health behaviours. METHODS This pilot study is funded by
GlaxoSmithKline Australia and recognised by the National Health and Medical Research Council through a
scholarship to S.A. The study has approval from the Human Research Ethics Committee of UNSW Australia
(HREC14139).
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BACKGROUND
Chronic obstructive pulmonary disease (COPD), third leading cause of
mortality worldwide,1 is primarily caused by cigarette smoking in
Australia.2 COPD often occurs in the presence of multi-morbidity,
which is the simultaneous occurrence of two or more chronic
conditions; this is a growing concern in a health system focused on
single-disease management.3 Around 80% of older Australians have
multi-morbidity, average prevalence of chronic respiratory disease
being 9.5%.4
A systematic review of COPD education programs suggests that
equipping patients with self-management skills is as important as
disease knowledge.5 Studies exploring positive effects of chronic
disease-management interventions6 also underline the lack of
studies aimed at empowering patients. Although a recent
Cochrane Review7 of COPD self-management interventions shows
increased health-related quality of life and decreased probability
of respiratory-related hospitalisation, similar interventions have
not been consistently effective when applied in recent trials.8–10
Though interventions aimed at modifying COPD-related health
behaviour have great potential, extant literature points to need for
self-management programs in primary care.
There is a dearth of interventions involving patients with multi-
morbidity, clinicians and other stakeholders, that can be
generalisable to other populations.11 Patients with multi-
morbidity are often excluded from chronic disease-management
trials; a Cochrane review12 of multi-morbidity interventions found
only ten such studies. Our recent qualitative study,13 which
explored the impact of COPD diagnosis in primary care patients
with co-morbidities (co-existing chronic conditions), found sub-
optimal disease understanding and health-care utilisation. The
above evidence demonstrates a need for development and
testing interventions to increase self-management capacity in
COPD patients with co-morbidities.
Even a brief education session is effective in improving disease
knowledge and response to symptoms;14 as demonstrated by self-
management interventions10, 15 on COPD which increased patient
self-efficacy. Such programs do not only improve health status
and prevent hospital remissions,16 but also lead to better patient-
provider relationships, self-efficacy and sense of identity.17 With
no prior study having seemed to focus on improving self-efficacy
of COPD patients with co-morbidities in primary care, our study
aims to empower these patients by trialling a tailored, practice
nurse -delivered self-management program.
AIMS
This pre and post-test pilot study aims to trial the impact and
feasibility of a tailored self-management program for primary care
COPD patients with multi-morbidity. Our hypothesis is that at six
months’ follow-up, participants would have:
1. Better activation in terms of their COPD-related health
behaviour.
2. Improved knowledge and self-management capacity of
COPD.
3. Increased self-efficacy in terms of their overall health
behaviours.
METHODS
This pilot study is funded by GlaxoSmithKline Australia and
recognised by the National Health and Medical Research Council
through a scholarship to S.A. The study has approval from the
Human Research Ethics Committee of UNSW Australia (HREC14139).
Inclusion/exclusion criteria
General practices will be eligible if they maintain an electronic
database of medical records and employ one or more practice
nurse (PN).
Patients will be eligible if they are aged between 40 and 84
years, have a recorded spirometry diagnosis of COPD and at least
one other co-morbidity. Exclusion criteria are poor understanding
of English and/or cognitive impairment.
Setting
The study will be conducted in general practices across Sydney,
Australia. Practices will be recruited from the UNSW Practice Based
Research Network that links practices, which have expressed interest
and/or have participated in previous research by S.D. and N.Z.
This is a pre and post-test study comprising a mixed method
design, with outcome measures to be collected at baseline and six
months’ follow-up. The protocol is summarised in Fig. 1.
Recruitment
An information sheet about the study will be faxed to invite
potential practices. S.A. will visit interested practices to answer
questions and obtain written informed consent from general
physician (GP)s and PNs. Practices who do not respond will be
followed up after two weeks.
Received: 14 April 2016 Revised: 11 September 2016 Accepted: 7 November 2016
1School of Public Health and Community Medicine, UNSW Medicine, UNSW Australia, Sydney, NSW 2052, Australia; 2South Western Sydney Local Health District, Faculty of
Health Sciences, The University of Sydney, Sydney, NSW 2141, Australia; 3Centre for Primary Health Care and Equity, UNSW Australia, Sydney, NSW 2052, Australia and 4School of
Medicine, Faculty of Science, Medicine and Health, University of Wollongong Australia, Wollongong, NSW 2522, Australia
Correspondence: Sameera Ansari (sameera.ansari@unsw.edu.au)
www.nature.com/npjpcrm
Published in partnership with Primary Care Respiratory Society UK
Staff from participating practices will identify potential patients
from their database based on inclusion criteria. PNs will then send an
invitation letter to eligible patients and remind non-responders after
two weeks by telephone. Interested patients will attend visit 1 at
their practice, during which S.A. will answer questions, obtain written
consent, and ask them to complete the baseline questionnaires.
Patient recruitment is deemed feasible as chronic respiratory
disease accounts for 12% of patient-GP encounters in Australia,
COPD being the 11th most common cause for general practice
visits.18 Recent COPD casefinding studies in Sydney19, 20 have
found high disease incidence.
PN training
PNs will attend a one-day work shop, facilitated by the
investigators, which will cover basic pathophysiology of COPD,
concept of multi-morbidity, the study design and rationale, COPD
self-management based on GOLD21 (Global strategy for the
diagnosis, management and prevention of COPD) and COPD-X22
(Australian-New Zealand COPD guidelines), medication adherence,
pulmonary rehabilitation, smoking cessation and principles of
motivational interviewing. The workshop aims to equip PNs
with knowledge and confidence to understand the intervention,
and enable them to tailor and deliver it to patients using an
assessment and planning template developed by the researchers.
PNs’ competency in delivering the intervention will be assessed
using case scenarios, with investigators enacting patients and
providing feedback. PNs’ understanding of the intervention and
feedback on the workshop will be obtained by means of an
evaluation form.
Intervention
The self-management program of this study is based on the Health
Belief Model (HBM),23 a widely-tested health education theory
explaining human decision-making and subsequent behaviour.
The assessment and planning template for the PN-patient
sessions incorporates the HBM’s constructs with strategies for self-
management of COPD and co-morbidities. The template includes
cues to:
1. COPD knowledge24, 25
2. Relationship between COPD and patients’ co-morbidities
3. Management and prioritisation of their multiple chronic
health conditions
4. Managing flare-ups using a COPD Action Plan26
5. Recommended exercises27 and pulmonary rehabilitation
6. Proper use of inhalers28, 29
7. Importance of flu and pneumonia vaccination30, 31
8. Medication review and adherence
9. Advice on overall health and wellbeing
10. Effects of smoking and benefits of quitting, assistance with
quitting and abstinence32
Links to relevant resources will be uploaded to a website for the
participants’ reference.
Visit1
• Researcher meets with patient for obtaining written consent and
collecting baseline data
Visit 2
• PN performs needs assessment and sets goals for patient
• Tailoring of intervention, goal setting and motivational 
interviewing
2 weeks
• Patient works towards set goals and reflects using weekly logs 
Visit 5
• Researcher meets with patient to collect post-test data
End of study
• Researcher interviews PNs and GPs for feedback on the intervention
Visit 3
• PN reviews patient's progress
• Motivational interviewing and further goal setting
• Referral to GP/other healthcare providers as needed
2 weeks
• Patient works towards set goals and reflects using weekly logs
Visit 4
• PN reviews patient's progress
• Motivational interviewing and further goal setting
• Referral to GP/other healthcare providers as needed
5 months
• PN calls patient each month to follow up
Fig. 1 Study protocol
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During the first PN-patient session (visit 2), individual patient
needs will be assessed, and the intervention tailored accordingly.
In the following two sessions (visits 3 and 4), PNs will use
motivational interviewing33 to address barriers faced by patients
in managing their COPD in the face of co-morbidities, and work
towards optimising health behaviour. The patients will maintain a
daily log about their health behaviour in between the education
sessions. The logistics of intervention delivery is based on the 5A’s
approach,34 which is an organisational tool devised to help
clinicians Ask, Advise, Assess, Assist and Arrange for their patients’
health behaviour.
Cues to action will be provided to patients in the form of
motivational fridge magnets and five follow-up phone calls at
monthly intervals by their PNs after the last session. During the
course of the intervention, GPs will be notified of situations
requiring medical attention (e.g., when treatment needs to be
intensified) by the PNs.
Outcome measures
Impact of the program will be determined by change in patients’
level of self-efficacy between baseline (visit 1) and six months’
follow-up (visit 5), using the Patient Activation Measure (PAM)
13,35 a highly-reliable, unidimensional scale of knowledge, skills
and confidence for self-management of their health.36 The PAM
classifies patients across four levels of activation, a significant
difference being an increase or decrease of at least one level.
Secondary outcome measures include COPD Knowledge Ques-
tionnaire (COPD-Q),37 COPD Assessment Test (CAT, an indicator of
COPD-related quality of life),38 Multimorbidity Illness Perceptions
Scale (MULTIPleS, to detect change in perceived impact of multi-
morbidity),39 a COPD-specific version of the MULTIPleS, Morisky
Medication Adherence Scale (MMAS-8)40 and accuracy of inhaler
technique.41 Relationship between objectives, hypothesis, out-
comes and measures is outlined in Table 1.
In accordance with Normalisation Process Theory,42 a reliable
framework for complex interventions, qualitative feedback will be
obtained at the end of the study from participating PNs and GPs
to examine feasibility and sustainability of the program.
Data analysis
Quantitative data will be analysed using Statistical Package for the
Social Sciences. Descriptive statistics of responses, expressed as
absolute and relative frequencies, will be generated. Categorical
data will be analysed by Chi-squared or Fisher’s exact test.
Student’s t-test for paired samples will be applied for comparing
differences in pre and post-intervention outcome measures.
Associations will be given as odds ratios.
Qualitative interview transcripts will be coded using NVivo
software and thematically analysed by an iterative process.
Sample size
In accordance with the recommended sample size for feasibility
studies demonstrating intervention efficacy in a single group,43
our pilot study requires 40 patients, allowing for a 20% drop-out
rate44 between baseline and six-month visits. This is sufficient to
detect a difference in paired measures of patient activation, as
demonstrated by a recent study45 which used the PAM 13 as an
outcome measure, with 85% power at the 5% significance level. A
significant difference would be a change between two adjacent
stages of the PAM.
Table 1. Relationship between objectives, outcomes, measures and hypotheses
Objective Hypothesis Outcome Measure Visit
To assess the impact of a PN-delivered
tailored self-management intervention
on COPD patients with multi-
morbidity
Tailored self-management education will
improve patients’ activation and engagement
in their health behaviour, knowledge and self-
efficacy of COPD, and increase confidence and
skills to manage their multi-morbidity
Change in knowledge, skills
and self-management



























Change in perceived impact













Accuracy of technique while







To assess the feasibility and
sustainability of the PN-delivered self-
management education program
Barriers and facilitators to
delivery of the intervention,







COPD chronic obstructive pulmonary disease, PN practice nurse
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Qualitative process evaluation
Following completion of the program, participating PNs and GPs
will be interviewed to gain their feedback. They will be invited via
email and written informed consent obtained for recording the
interviews, which will be conducted face-to-face by S.A. The
interviews will be semi-structured with open ended questions
covering their experience and opinions regarding the study, as
well as feasibility and sustainability of the program. The interview
transcripts will be analysed thematically and coded using NVivo
software.
DISCUSSION
To our knowledge, this study is the first aimed at improving self-
efficacy of primary care COPD patients with co-morbidities.
Primary care is the ideal setting for implementing self-
management interventions because early-stage COPD is typically
diagnosed and managed in this setting. Our tailored, PN-delivered
education program might not only benefit these patients, but
could also upskill the PNs’ role in chronic disease management.
According to the UK Medical Research Council framework for
complex interventions,46 feasibility studies like ours are a vital step
for overcoming problems with acceptability, compliance, interven-
tion delivery, participant recruitment, retention and follow-up, and
effect size in larger intervention studies. Our study would be
enriched by qualitative feedback from patient participants, but this
will extend the data collection process and is hence a limitation.
Experience of intervention delivery and uptake from our pilot
study would help refine the intervention and shed light on its
acceptability and feasibility in day-to-day general practice,
providing an evidence base for upscaling the intervention to be
tested in a randomised controlled trial. This capacity-building
initiative would also promote collaboration and knowledge
translation between the various stakeholders.
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